Preliminary Program: MONDAY MAY 22
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
IS26. Clinical Implications of Choices of Atypical Antipsychotics: Realities and Myths (Part 1)Supported by Bristol-Myers Squibb Co.
Impact of Short-Term Decision on Long-Term Outcomes Stephen R. Marder, M.D. | |||||
Neurocognition, Functional Outcomes, and Psychopharmacology Michael Green, M.D. | |||||
IS27. Evidence, Outcomes, and Advocacy: Shaping the Management of GAD (Part 1)Supported by Cephalon Inc.
Evidence-Based Advocacy: A Data-Driven Look at the Somatic Expression of GAD Philip R. Muskin, M.D. | |||||
Comorbidity in GAD: A Public Health Challenge John L. Beyer, M.D. | |||||
IS28. Attaining and Sustaining Remission in Treatment of Depression With Comorbid or Residual Anxiety (Part 1)Supported by Wyeth Pharmaceuticals
Impact of Associated Anxiety Symptoms on Depression Peter P. Roy-Byrne, M.D. | |||||
Collaborative Management Strategies for Patients With Comorbid Anxiety With Depression Wayne J. Katon, M.D. | |||||
Strategies to Achieve and Sustain Remission Shaily Jain, M.D. | |||||
Residents Session
Meet the Experts: Sunny-Side Up
7:30 a.m.-5:30 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 38-43
8 a.m.-5 p.m.
CME Course 44
9 a.m.-10:30 a.m.
Clinical Case Conferences
| 1. | Honorable Discharge: Severe Brain-Injured Psychological Symptoms in the Female VeteranSusan Stabinsky, M.D., Michael Blumenfield, M.D., Capt. Frances Stewart, M.D., Maria Tiamson, M.D. (for APA members only) | ||||
| 2. | Sealed With a Kiss: Using the Sexual History in Psychodyamic PsychotherapyJennifer I. Downey, M.D., Richard C. Friedman, M.D., Diane McLean, M.D., Ph.D.(for APA members only) | ||||
Debate
1. Resolved: Does CATIE Really Inform the Practice of Psychotherapy?Moderator: Richard E. D'Alli, M.D.
Discussion Groups
| 1. | Laura Roberts, M.D., on TBD (Meet the Authors) | ||||
| 2. | Donna E. Stewart, M.D., on Why Women's Mental Health (Meet the Authors) | ||||
| 3. | Jesse H. Wright, M.D., on TBD (Meet the Authors) | ||||
| 4. | Michelle B. Riba, M.D., M.S., on TBD (Meet the Authors) | ||||
Focus Live Session 1.Presenter: Glen O. Gabbard, M.D., on Personality Disorders
Lectures
L2. Culture, Spirituality, and Psychiatry: A Psycho-Historical Study of King SaulAlbert C. Gaw, M.D., APA's Kun-Po Soo Award Lecture
L3. Rediscovering Our Place in the WorldDavid T. Suzuki, Ph.D., Frontiers of Science Lecture Series
L4. The Search for Quality and Equity in Care for Psychiatric Disorders: A Story of Opportunity, Evidence, and PartnersKenneth B. Wells, M.D., APA's Research in Psychiatry Award Lecture
Master Educator Clinical Consultations
| 1. | Renato Alarçon, M.D., on Clinical Dimensions of Cultural Psychiatry | ||||
| 2. | Laura J. Miller, M.D., on Psychiatric Disorders Across the Female Reproductive Cycle | ||||
| 3. | Meera Narasimhan, M.D., on Refractory Depression: Diagnostic and Treatment Implications | ||||
New Research Young Investigators' Poster Session 1
Component Workshops
CW1. Disaster Psychiatry: Practical Skills to Help District Branches Develop Disaster Plans for Their CommunitiesAPA Committee on Psychiatric Dimensions of Disasters; Co-Chairpersons: Lisa A. Catapano, M.D., Christina V. Mangurian, M.D.
CW2. Pay for Performance: Linking Incentives to Provider Performance on Quality MeasuresAPA Council on Quality Care and APA Council on Healthcare Systems and Financing; Co-Chairpersons: Richard C. Hermann, M.D., Bruce J. Schwartz, M.D.
CW3. Career Choices in Psychiatry: Exploring Fellowship TrainingAPA Assembly Committee of Area Member-in-Training Representatives; Chairperson: Vincent J. Blanch, M.D.
CW4. Severely Mentally Ill Persons in Jails and Prisons: Who Should Stay?APA Corresponding Committee on Jails and Prisons; Chairperson: Henry C. Weinstein, M.D.
CW5. Crime and Cruel, Not Unusual Punishment: The Need for Juvenile Justice Mental Health Care ReformAPA Alliance; Chairperson: Louis J. Kraus, M.D.
CW6. Closing a Practice: What Every Psychiatrist's Office and Their Family Should KnowAPA Corresponding Committee on Physician Health, Illness, and Impairment; Chairperson: John A. Fromson, M.D.
CW7. Conquering the Shame, Secrecy, and Stigma of Suicide in Young Asian-American AdultsAPA Committee of Asian-American Psychiatrists; Chairperson: Surinder S. Nand, M.D.
CW8. CPT Coding and Documentation UpdateAPA Committee on RBRVS, Codes, and Reimbursements; Chairperson: Chester W. Schmidt Jr., M.D.
CW9. New Developments in APA Practice Guidelines on Bipolar Disorder, MDD, and Panic DisorderAPA Steering Committee on Practice Guidelines; Chairperson: Jack S. McIntyre, M.D.
Issue Workshops
IW1. A Dimension of Mind: Simulations/Emulations of Psychiatric Symptoms Using the Performing Art of MagicChairperson: Bruce C. Ballon, M.D.
IW2. What Do You Do With a Patient Who Has Access to a Gun?Chairperson: Donna M. Norris, M.D.
IW3. Managing Complex Comorbid Psychiatric and Alcohol Use Disorders in Psychiatric PracticeCollaborative Session With the National Institute on Alcohol Abuse and Alcoholism; Chairperson: Mark L. Willenbring, M.D.
IW4. Extrapyramidal Side Effects and Tardive Dyskinesia in the Atypical Antipsychotic EraChairperson: Thomas E. Hansen, M.D.
IW5. Neurocybernetics: Novel Approach in the Treatment of Psychiatric Disorders Chairperson: Alan L. Summers, M.D.
IW6. Treatment of Pregnancy-Related Mood Disorders: From Psychiatry to PediatricsCo-Chairpersons: Janet A. Martin, M.D., Syed S. A. Naqvi, M.D.
IW7. Risk Management Issues in Psychiatric PracticeChairperson: Alan I. Levenson, M.D.
IW8. But Can We Do It Here? Challenges of Implementing Cognitive-Behavior Therapy for Schizophrenia Programs in the U.S.Co-Chairpersons: Page Burkholder, M.D., Peter J. Weiden, M.D.
IW9. Religious and Spiritual Assessment in Clinical PracticeCo-Chairpersons: Francis G. Lu, M.D., Christina M. Puchalski, M.D.
IW10. Early Detection and Treatment of Bipolar IllnessChairperson: Eric R Marcus, M.D.
IW11. What Is a Mood Stabilizer?Chairperson: Eduard Vieta, M.D.
IW12. Reinventing Careers: Transitions and Later-Life Strategies for PsychiatristsCo-Chairpersons: Carolyn B. Robinowitz, M.D., Abram M. Hostetter, M.D.
IW13. American Board of Psychiatry and Neurology Update: Certification and Maintenance of Certification in Psychiatry and Its SubspecialtiesChairperson: Stephen C. Scheiber, M.D.
IW14. New Research Advances in EthnopsychopharmacologyCo-Chairpersons: Pedro Ruiz, M.D., William B. Lawson, M.D.
IW15. Online Peer Support Groups and Support Group MembersChairperson: Robert C. Hsiung, M.D.
9 a.m.-Noon
Media Workshops
MW1.“Go”: A Triple-Take in the World of DrugsCo-Chairpersons: Petros Levounis, M.D., Jose P. Vito, M.D.
MW2. “Do I Look Fat?”Eating Disorder Pathology in Gay MenChairperson: Daniel Garza, M.D.
9 a.m.-4 p.m.
CME Courses 45-50
10 a.m.-5:30 p.m.
Exhibits Open
APA Member Center Open Publishers' Bookfair Open
11 a.m.-12:30 p.m.
Discussion Groups
5. Jack Drescher, M.D., on The Psychology of the Closet
6. Nathan Strahl, M.D., on TBD (Meet the Authors)
7. John Oldham, M.D., on TBD
8. Ashwin Patkar, M.D., on TBD
9. Marian I. Butterfield, M.D., on Challenges Unique to Women Psychiatrists (for residents only)
Focus Live Session 2.Presenters: Joel Yager, M.D., and Stephen B. Levine, M.D., on Eating Disorders and Sexual Disorders
Lectures
L5.TBDPedro L. Delgado, M.D., APA's Simon Bolivar Award Lecture
L6. Emotional Processing and Schizophrenia: Neuropsychiatric PerspectivesRaquel Gur, M.D., Distinguished Psychiatrist
L7.The Discourse on Human Sexuality and AIDSAnke Ehrhardt, Ph.D., Frontiers of Science Lecture Series
Master Educator Clinical Consultations
4. Shaila Misri, M.D., on Perinatal Psychiatric Disorders on Current Issues in Pregnant and Postpartum Mothers (for APA members only)
5. Marion Goldstein, M.D., on Late Life Aging Processes and Mental Illness (for APA members only)
6. David Baron, D.O., Geetha Jayaram, M.D., on Clinical Research Across Geographic Borders: Challenges and Opportunities (for APA members only)
Medical Update 1.Heather Ross, M.D., on Congestive Heart Failure
Research Consultation 1.Mark L. Willenbring, M.D., on Clinical Research on Alcohol Use Disorders Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism
Scientific and Clinical Reports
Session 1. Presidential Theme: From Science to Public Policy: Advocacy for Patients and the Profession
1. The Impact of an Integrated Community Arts Studio on Stigmatizing Beliefs and Experiences Thomas C. Zelnik, M.D.
2. Health Policies and the Diagnostic and Statistical Manual Roger Peele, M.D.
3. The System for Classification of Inpatient Psychiatry: A New Case-Mix Methodology for Mental Health John P. Hirdes, Ph.D.
Session 2. Ethics and Human Rights
4. Ethics and Psychobiological Research Cherise Rosen, Ph.D.
5. Terrorism and Medical Ethics: Conflicting Loyalties for American Psychiatrists David A. Rothstein, M.D.
6. A New Mental Health Act: An Australian Experience Darryl P. Watson, M.D.
Session 3. Attention Spectrum Disorders
7. Transdermal Methylphenidate Versus Placebo in Pediatric ADHD Robert L. Findling, M.D.
8. Effects of Transdermal Methylphenidate in a Laboratory Classroom Study James J. McGough, M.D.
9. Modafinil-ADHD: Long-Term Efficacy and Safety in Children and Adolescents With ADHD Samuel W. Boellner, M.D.
Session 4. Current Trends in Schizophrenia
10. Recurring Psychosis in Schizophrenia: A 20-Year Multi, Follow-Up Study Martin Harrow, Ph.D.
11. Identifying the Neurobiological Basis for Schizophrenia Zeinab S. Elbaz, M.D.
12. Key Findings From the Intercontinental Schizophrenia Outpatients Health Outcomes Study (IC-SOHO): Disease Burden and Clinical Outcomes Associated With Antipsychotic Treatment for Schizophrenia Martin Dossenbach
Session 5. Medication Response in MDD
13. Duloxetine Versus Escitalopram and Placebo in the Long-Term Treatment of Patients With MDD Teresa A. Pigott, M.D.
14. Conditional Probability of Response to Placebo in MDD Jennifer Covino, M.P.A.
15. Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study David Michelson, M.D.
Session 6. Treatment Management and Outcomes in Mood Disorders
16. Management of Side Effects Associated With New Treatments for Bipolar Depression Joseph R. Calabrese, M.D.
17. Treatment-Resistant Depression: Changes in Symptoms and Functioning in a Clinical Sample Alex A. Cardoni, M.S.
18. Specificity of Effect of Quetiapine in Bipolar Depression Robert M. A. Hirschfeld, M.D.
Session 7. Diagnostic Issues
19. Screening for History of Physical, Emotional, and Sexual Abuse: How Do We Ask About Abuse? Brett D. Thombs, Ph.D.
20. Kennedy Axis V: The Next Step for Axis V? James A. Kennedy, M.D.
21. Dimensional Approaches to DSM and the Impact on Diagnostic Instruments Maritza Rubio-Stipec, Sc.D.
Session 8. Consultation-Liaison Psychiatry
22. Teaching of Psychiatry in Primary Care Residencies: Do Training Directors of Primary Care and Psychiatry See Eye to Eye? Hoyle Leigh, M.D.
23. Unrecognized Post-Traumatic Symptoms Triggered by Routine Hospital Care in Patients With Previous Trauma Histories Sarah Birmingham, M.D.
24. Is Asthma Severity Related to Current Major Depressive Episode and Generalized Anxiety Disorder? A Case-Control Study Claudia Meneses, M.D.
Session 9. Psychiatric Education
25. Psychiatric CMEs and Commercial Bias: Are New ACCME Standards Effective? Daniel J. Carlat, M.D.
26. Relationships Between Self-Assessment Skills, Test Performance, and Other Variables in Psychiatry Residents David J. Lynn, M.D.
27. Coaching Communication Using Standardized Patient Encounters: An Educational Research Study Paula Ravitz, M.D.
Session 10. Biological Psychiatry and Neuroscience
28. From Synapse to Psychotherapy: The Fascinating Evolution of Neuroscience Bernadette Grosjean, M.D.
29. Can Neurological Soft Signs Discriminate Between Four Axis-I Diagnostic Categories in the Prison Population? Seyed Mohammad Assadi, M.D.
30. An Association Study of a Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Zotepine Response of Inpatients With Acute Schizophrenia Ching-Hua Lin, M.D.
Session 11. Geriatric Psychiatry
31. The Influence of Dementia on the Treatment of Depression in Geriatric Inpatients John W. Goethe, M.D.
32. Overall Efficacy and Time to Response for Duloxetine 60 mg Once Daily Versus Placebo in Elderly Patients With MDD Joel Raskin, M.D.
33. Safety and Efficacy of Intra-Muscular Ziprasidone Treatment of Acute Psychotic Agitation in Elderly Patients With Schizophrenia Alex Aviv
Component Workshops
CW10. The Gift of Life: A Psychiatric Perspective on Living Hepatic Organ DonationAPA Council on Psychosomatic Medicine; Co-Chairpersons: Philip R. Muskin, M.D., Silvia Hafliger, M.D.
CW11. Toward a Better Understanding of Cultural Issues in Clinical Practice: Residents' Perspective of a Model Curriculum for Residency Training ProgramsAPA/AstraZeneca Minority Fellows; Chairperson: Angel A. Caraballo, M.D.
CW12. Ethnicity and Caregiving Across the Psychiatric SpectrumAPA Committee on Ethnic Minority Elderly; Co-Chairpersons: Iqbal Ahmed, M.D., Warachal E. Faison, M.D.
CW13. Sexuality and Its Impact on the HIV PandemicAPA Committee on HIV/AIDS; Chairperson: Marshall Forstein, M.D.
CW14. Psychiatric Ethics in the United States and Throughout the WorldAPA Ethics Committee; Co-Chairpersons: Spencer Eth, M.D., George Christodoulou, M.D.
CW15. Teaching the Working Alliance as a Core Process Across the PsychotherapiesAPA Committee on Psychotherapy by Psychiatrists; Chairperson: Eric M. Plakun, M.D.
CW16. Scales in the Clinical Practice of Geriatric PsychiatryAPA Committee on Access and Effectiveness of Psychiatric Services for the Elderly; Chairperson: Allan A. Anderson, M.D.
CW17. Winning the Fight for Mental Health Benefits: Partnering With EmployersAPA Committee on APA/Business Relationships; Chairperson: Dauda A. Griffin, M.D.
CW18. Culture as a Rationalization for Violence Against WomenAPA Committee on Family Violence and Abuse; Chairperson: Gail E. Robinson, M.D.
CW19. Facilitating Minorities to Excel in Academic PsychiatryAPA Assembly Committee of Representatives of Minority/Underrepresented Groups; Chairperson: Jagannathan Srinivasaraghavan, M.D.
Issue Workshops
IW16. Assessment of Capacity: Developments, DVDs, and Defense OrganizationsChairperson: M.E. Jan Wise, M.R.C. Psych.
IW17. Biopsychosocial and Spiritual Aspects of Treating Our Physician ColleaguesCo-Chairpersons: Monisha R. Vasa, M.D., Syed S. A. Naqvi, M.D.
IW18. Oral Boards Boot Camp: 2006Chairperson: Elyse D. Weiner, M.D.
IW19. The Other Desperate Housewives: Hidden Violence in the HomeChairperson: Susan J. Hatters-Friedman, M.D.
IW20. Treating First- and Second-Generation Immigrants With Psychotherapy During Residency TrainingChairperson: Anu A. Matorin, M.D.
IW21. Physician Heal Thyself: Workplace Burnout Among PsychiatristsCo-Chairpersons: John Sharkey, M.D., Steve Choong Kam Chong, M.D.
IW22. Psychotherapy Training and International Medical Graduates: The Influence of Cultural FactorsChairperson: Nyapati R. Rao, M.D.
IW23. Cognitive-Behavior Therapy for Psychosis: Basic Techniques for PsychiatristsChairperson: Shanaya Rathod, M.D.
IW24. Teaching Cognitive-Behavior Therapy to ResidentsCo-Chairpersons: Judith S. Beck, Ph.D., Donna M. Sudak, M.D.
IW25. Establishing a Women's Mental Health Program in an Academic or Private SettingCo-Chairpersons: Catherine A. Birndorf, M.D., Nehama Dresner, M.D.
IW26. Secrets in Family Therapy: To Tell or Not to TellCo-Chairpersons: Eva C. Ritvo, M.D., Michael Hughes, M.D.
IW27. Virtual Reality and Video Games in the Treatment of Mental Health Disorders and Addictions: An Evidence-Based AnalysisCo-Chairpersons: William Huang, M.D., Jeffery N. Wilkins, M.D.
IW28. Multidisciplinary Treatment of Adults With Asperger's Syndrome and Related Disorders: Lessons From the University of Pennsylvania Social Learning Disorders ProgramCo-Chairpersons: Anthony L. Rostain, M.D., Edward S. Brodkin, M.D.
Noon-1:30 p.m.
Forums
| 1. | Harry Potter and the Half-Blood Prince: Harry Grows UpChairperson: JoAnne Isbey, A.B.D. | ||||
| 2. | DSM-V Chairperson: Darrel Regier, M.D. | ||||
| 3. | Mozart at 250: The Mind and Music of a GeniusChairperson: Richard Kogan, M.D. | ||||
| 4. | Women and Alcohol Use Disorders,Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism; Chairperson: Shelly F. Greenfield, M.D. | ||||
| 5. | The Theory and Practice of ApologyChairperson: Aaron Lazare, M.D. | ||||
1 p.m.-2:30 p.m.
New Research Young Investigators' Oral/Slide Sessions 2-4
1 p.m.-5 p.m.
CME Courses 51-57
2 p.m.-3:30 p.m.
Focus Live Session 3.Presenter: Jerald Kay, M.D., on Psychotherapy
Lectures
L8. Heart Rate Variability and Psychiatry: Beyond Heart-Mind LinkKrishnamachari Srinivasan, M.D., International Lecture
L9. New Advances in Cognitive TherapyAaron T. Beck, M.D., APA's Adolf Meyer Award Lecture
2 p.m.-5 p.m.
Presidential Symposium 1.
The Public Mental Health System: Critical Issues APA Committee on Family Violenceand Abuse and Council on Social Issues and Public Psychiatry; Chairperson: Yvonne B. Ferguson, M.D.
Symposia
S1. HIV Prevention Interventions With Psychiatric Patients From Around the World: Turning Research Into Practice
SMI HIV Research Trajectory and Needs Karen McKinnon M.A. | |||||
Ethnography of HIV Risk in Two Psychiatric Settings Paulo E. Mattos | |||||
Severe Mental Illness and HIV Risk in India With an Emphasis on the Special Threats to Women Prabha S. Chandra, M.D. | |||||
HIV Prevention and People With Mental Illness in South Africa: Prevalence, Policies, and Practice Pamela Y. Collins | |||||
HIV Risk and Risk-Reduction Efforts Among Persons Having Serious Mental Illness and Substance Use Issues in the U.S. Laura Otto-Salaj, Ph.D. | |||||
S2. Therapeutic Misconception in Clinical Research
Therapeutic Misconception: An Overview of the Phenomenon Paul S. Appelbaum, M.D. | |||||
How Prevalent Is Therapeutic Misconception? Charles W. Lidz, Ph.D. | |||||
Assessment of Therapeutic Misconception in Older Patients With Schizophrenia Laura B. Dunn, M.D. | |||||
Reaching Consensus on the Conceptual Definition of Therapeutic Misconception Gail Henderson | |||||
The Ethical Significance of the Therapeutic Misconception Franklin G. Miller, Ph.D. | |||||
S3. Migration and Mental Illness Around the WorldRoyal College of Psychiatrists
Refugee Mental Health Challenges in Africa Frank G. Njenga, M.D. | |||||
Mental Health of Sudanese Refugees: An Egyptian Perspective Nasser F. Loza, M.D. | |||||
PTSD Among a Group of Afghan Refugees Attending a Psychiatric Service in Peshawar, Pakistan Khalid A. Mufti, M.D. | |||||
Immigration-Repatriation and Mental Health: The Case of Greece George G. Christodoulou, M.D. | |||||
Raised Incidence of Psychosis in Ethnic Minority Groups in the U.K.: The AESOP Study Paul Fearon | |||||
Migration and Mental Health in Canada: Can Provincial Policy Help? Stephen R. Kisely, M.D. | |||||
S4. Psychosocial Intervention and Cancer Survival
Supportive-Expressive Group Therapy and Survival in Patients With Metastatic Breast Cancer: A Randomized Clinical Intervention Trial David Spiegel, M.D. | |||||
RCT of Supportive-Expressive Group Therapy in Advanced Breast Cancer: Survival, Psychosocial, and AntiCancer Treatment Adherence Outcomes David W. Kissane, M.D. | |||||
Treatment Outcomes of Group Supportive-Expressive Therapy for Women With Metastatic Breast Cancer Molyn Leszcz, M.D. | |||||
Impact of Psychotherapeutic Support on Gastrointestinal Cancer Patients Undergoing Surgery: 10-Year Follow-Up Survival Results of a Randomized Trial Thomas Kuechler, Ph.D. | |||||
Malignant Melanoma: Effects of a Brief, Structured Psychiatric Intervention on Survival and Recurrence at 10-Year Follow-Up Fawzy I. Fawzy, M.D. | |||||
S5. Sexual Orientation and SportsInternational Society for Sport Psychiatry
Being Gay in Sports Eric D. Morse, M.D. | |||||
Gender Role Conflict in Female Athletes Altha J. Stewart, M.D. | |||||
Suicide and the Homosexual Athlete Antonia L. Baum, M.D. | |||||
S6. Insomnia: What Is It?
Insomnia: Diagnosis and Treatment Challenges Thomas W. Uhde, M.D. | |||||
Epidemiology of Chronic Insomnia Edward Bixler, Ph.D. | |||||
Chronic Insomnia: Cause-Effect Relationship to Depression and Anxiety Disorders Ravi K. Singareddy, M.D. | |||||
A Vgontzas Biological Model of Chronic Insomnia: Clinical Implications Alexandros Vgontzas, M.D. | |||||
Health Correlates of Insomnia in Young Adults Antonio Vela-Bueno, M.D. | |||||
S7. The African Diaspora: Identifying and Eliminating Barriers to Mental Health
African Belief Systems and Corresponding Healing Practices Samuel O. Okpaku, M.D. | |||||
Why Is Stigma so Rife in Nigeria? Oye Gureje | |||||
The Haitian Diaspora: Barriers in Accessing Mental Health Services Mary Titus-Villedrouin | |||||
Barriers to Mental Health Service Delivery to Ethiopian Immigrants and Refugees in the U.S.: How Should We Tackle This Problem? Yeshashwork Kibour | |||||
The Postcolonial Challenge to the Stigma of Mental Illness in Jamaica Frederick W. Hickling, M.D. | |||||
Stigma and Mental Health: A South African Perspective Solomon Rataemane | |||||
S8. Treatment Issues in Schizophrenia With Comorbid DisordersAmerican Association of Practicing Psychiatrists
TBD Robert R. Conley | |||||
Treatment of Schizophrenia With Obsessive-Compulsive Disorder Michael Y. Hwang, M.D. | |||||
Substance Abuse Among Patients With Schizophrenia Spectrum Disorders Douglas Noordsy, M.D. | |||||
Cognitive Functioning and Outcome in Schizophrenia Philip D. Harvey, Ph.D. | |||||
Schizophrenia and Comorbid Aggressive Behavior: Update 2006 Leslie L. Citrome, M.D. | |||||
Eating Disorders in Schizophrenia Sun Young Yum, M.D. | |||||
S9. Rehabilitation in France, Canada, and the U.S.: From Science to Recovery: A Joint Meeting With the French Psychiatric Association: Vive la Difference
Neuropsychological Therapy Protocol on Young Schizophrenia Patients in Day Hospitals Christine Germain | |||||
Implementing Innovative Rehabilitation Modules: The Case of IPT in a Canadian Province Site Alain D. Lesage, M.D. | |||||
Recovery From Schizophrenia: Current Research Robert P. Liberman, M.D. | |||||
Evidence-Based Practices and Recovery in Schizophrenia Alan S. Bellack, Ph.D. | |||||
A New Rehabilitation Program for Schizophrenia Patients: Development and Preliminary Results Christophe Lancon | |||||
S10. Model Curricula on Religion and Spirituality for Psychiatry Residency Training Programs
Development of a Departmental-Based Curriculum of Spirituality in Health Care for Psychiatry Residents, Other Health Care Professionals, and Clergy/Pastoral Care Professionals Joan M. Collison, M.D. | |||||
Incorporating a Spiritual World View Within Psychiatry in the Bible Belt: University of South Carolina/Palmetto Health Curriculum on Spirituality Nioaka N. Campbell, M.D. | |||||
Bridging the Gap: Science and Spirituality Patricia E. Murphy, Ph.D. | |||||
The Interface Between Spirituality, Religion, and Psychiatry: A Course for Psychiatry Residents at the University of British Columbia Andrea D. Grabovac, M.D. | |||||
Spirituality and Psychiatry: The Harvard Longwood Course Psychiatry Residency Course: Eight Years Later John R. Peteet, M.D. | |||||
S11. The Long-Term Care and Treatment of Elderly Patients With Bipolar DisorderAPA Council on Aging
The Impact of Elderly Patients With Bipolar Disorder on the Health Care System Helen H. Kyomen, M.D. | |||||
Predictors of Functioning and Treatment of Community Dwelling Older People With Bipolar Disorder Sarah Pratt, Ph.D. | |||||
Treatment Interventions for Elderly Patients With Bipolar Disorder Melanie T Gentry, M.D. | |||||
Ethnic and Cultural Issues in the Care of Elderly Patients With Bipolar Disorder Iqbal Ahmed, M.D. | |||||
S12. When Usual Treatments Fail: Augmentation Strategies for Refractory Schizophrenia
Herbal Medicinal Strategies in Refractory Schizophrenia Richard P. Brown, M.D. | |||||
NMDA Intervention Strategies in Refractory Schizophrenia Guochuan E. Tsai, M.D. | |||||
Augmentation Strategies for the Patient With Treatment-Refractory Schizophrenia Peter F. Buckley, M.D. | |||||
S13. Substance Use Disorders in the U.S.Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism
Prevalence and Correlates of Prescription Drugs Nonmedical Use and Use Disorders in the U.S.: 1991-1992 and 2001-2002 Carlos Blanco-Jerez, M.D. | |||||
Alcohol and Drug Dependence and the Specificity of Family History Deborah S. Hasin, Ph.D. | |||||
Prevalence, Correlates, and Comorbidity of DSM-IV Drug Use Disorders Bridget F. Grant, Ph.D. | |||||
Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Kevin Conway, Ph.D. | |||||
The Relationship of Family History to Cocaine and Cannabis First Use and Dependence Gary Heiman, Ph.D. | |||||
S14. The Mid-Life Crisis as Interpreted in Film and Television
Depression and Other Psychopathology at Mid-Life Anton C. Trinidad, M.D. | |||||
The Mind of the Mid-Life TV Addict Robert J. Boland, M.D. | |||||
TBD Josepha A. Cheong, M.D. | |||||
S15. First-Episode Schizophrenia: How Can We Improve Treatment Outcome?
Measures to Prevent Relapse in Long-Term Treatment: Results From the German Research Network on Schizophrenia Wolfgang Gaebel, M.D. | |||||
The European First Episode Schizophrenia Trial René S Kahn, M.D. | |||||
Management of Impaired Cognition Stephen R. Marder, M.D. | |||||
Social Cognition in Schizophrenia: Impairments and Psychological Treatment Wolfgang Woelwer, Ph.D. | |||||
Effects of Pharmacolgical Treatment on the Quality of Life George Awad, M.D. | |||||
S16. Adolescent Brain Development: Implications for Psychiatric TreatmentNational Institute on Drug Abuse
Adolescent Brain Development: A Period of Vulnerabilities and Opportunities Ronald E. Dahl, M.D. | |||||
Interacting Effects of Cannabis and Tobacco Use on Brain Function in Adolescents Leslie K. Jacobsen | |||||
Prefrontal-Limbic Brain Maturation and Risk for Psychopathology in Adolescence Isabelle M. Rosso, Ph.D. | |||||
The Immature Adolescent Brain and Cognitive Control Beatriz Luna, Ph.D. | |||||
S17. Ethnicity, Age, and Gender as Factors in the Management of Anxiety and Depression
A Clinical Update on Response Rates in Psychiatric Disorders and Ethnicity DiAnne Bradford, M.D. | |||||
Identifying and Treating Depressive and Anxiety Disorders in Children and Adolescents Melissa P. DelBello, M.D. | |||||
Treatment Considerations in Special Populations: Sex Differences Diana O. Perkins, M.D. | |||||
New Pharmacologic Approaches in Treating Depression and Anxiety David E. Adson, M.D. | |||||
S18. Personality Disorders and Comorbidity: Predictive Factors and Clinical Implications
Personality Disorders and Affective Disorders: Ploughing the Sands or Fertile Soil? Predictors and Clinical Implications Simone Kool, M.D. | |||||
Efficacy of Depression Treatment in Patients With or Without Comorbid Personality Disorders: Does Clinical Lore Reflect the Findings From the Literature? Robert A. Schoevers, M.D. | |||||
The Relation Between Personality Pathology and Pathological Gambling R. Michael Bagby, Ph.D. | |||||
Gender Differences in Personality Disorders Among Depressed Outpatients as Compared to the General Population Cecilia M.T. Gijsbers Van Wijk, Ph.D. | |||||
Drug Treatment of Personality Disorder: A Critical Review Thomas Rinne, M.D. | |||||
S19. Toward a Developmental Trauma Disorder
Childhood Abuse, Regional Brain Development, and Psychiatric Vulnerabilities: Evidence for Sensitive Periods Martin H. Teicher, M.D. | |||||
Developmental Trauma Disorder: Evidence From the Adolescent Years Marylene Cloitre, Ph.D. | |||||
Empirical Foundations for a Developmental Trauma Disorder Bessel A. Van Der Kolk, M.D. | |||||
Developmental Trauma Disorder: A Missing Link in Child Psychiatric Nosology and Treatment Planning Julian Ford | |||||
Child Trauma History Profile, Interference With Developmental Competencies, and Influence on Other Major Psychiatric Disorders in Children and Adolescents Robert S. Pynoos, M.D. | |||||
S20. Borderline Mothers and Infant Interactions: Chaotic Contingency
Neurobiological Insights Into the Consequences of Early Nurturing Experience Cort A. Pedersen, M.D. | |||||
Distortion of Borderline Mothers and Infant Interaction and Emotional Regulation at Three Months Gisèle Apter-Danon, M.D. | |||||
Practical Applications of Treating Women in the Postpartum Period Samantha E. Meltzer-Brody, M.D. | |||||
Interventions for New Mothers With PTSD and BPD Marian I. Butterfield, M.D. | |||||
S21. Criminalization of Mental Illness: Getting In and Out in New YorkAmerican Association for Social Psychiatry
Only Some People With Mental Illness Are Criminalized Zebulon C. Taintor, M.D. | |||||
Substance Abuse, Spirituality, and Deviant Behavior Marc Galanter, M.D. | |||||
Mental Health Treatment in New York State Prisons and Outcome Abraham L. Halpern, M.D. | |||||
Alternatives to Incarceration: Assisted Outpatient Treatment and Drug Courts Gary R. Collins, M.D. | |||||
S22. Psychocultural Foundations of Political TerrorismAPA Council on Global Psychiatry and International Society of Political Psychology
Combating the Virus of Islamist Militancy: A Public Health Perspective Jerrold M. Post M.D. | |||||
Toward a Scientific Revolution in the Application of Behavioral Sciences to the Study of the Deep Roots of Terrorism Jeff Victoroff, M.D. | |||||
The Appeal of Radical Islam for Young British Muslims Amy Waldman | |||||
Terrorism and Diasporas Stevan M. Weine, M.D. | |||||
Religion and Terrorism in U.S. Prisons: Crucible for Commitment or Contagion? Gregory B. Saathoff, M.D. | |||||
Moral Agents, Immoral Violence: Mechanisms of Moral Disengagement in Islamic Suicide Missions Mohammad Hafez | |||||
S23. Science, Diagnoses, and the ClinicianWorld Psychiatric Association
A Proposal to Include a Dimensional Component in DSM-V John E. Helzer | |||||
Dualism and the DSM: Emerging from the Shadow of the 17th Century G. Scott Waterman, M.D. | |||||
DSM in the 21st Century and Beyond: The Interface of Genomics and Neuroscience With Our Diagnostic System James J. Hudziak, M.D. | |||||
Improving the Validity of DSM Categories Lee N. Robins, D. Phil. | |||||
S24. The Effective Psychotherapist: The Role of Common and Specific Factors
Factors Common to All Evidence-Based Psychotherapies John Manring, M.D. | |||||
Cognitive-Behavioral Therapy for Anxiety Disorders: Common and Specific Aspects Edna B. Foa, Ph.D. | |||||
Integrating Common and Specific Factors in Psychotherapy Training: McMaster and Syracuse Models Priyanthy Weerasekera, M.D. | |||||
TBD Scott P. Stuart, M.D. | |||||
S25. Developing Strategies in Psychotherapy Research
Assessing the Quality of Randomized, Controlled Trials of Psychotherapy Andrew J. Gerber, M.D. | |||||
Long-Term Outcome in Psychotherapy Research James H. Kocsis, M.D. | |||||
An Outcome Study for Psychoanalysis Steven P. Roose, M.D. | |||||
Comparison and Combination of | |||||
Psychotherapy and Medication in Outcome Trials Michael E. Thase, M.D.
S26. Taking Science to Policy: Efforts to Reduce Harms Related to Alcohol MisuseCollaborative Session With the National Institute on Alcohol Abuse and Alcoholism
The Magnitude and Prevention of Underage Drinking Problems Ralph Hingson | |||||
Pragmatic Science: The New NIAAA Clinician's Guide Mark L. Willenbring, M.D. | |||||
Alcohol Interventions in Trauma Centers Reduce Reinjury Rates: State Laws and Insurance Regulations Prevent Their Implementation Larry Gentilello | |||||
Implementing Alcohol Treatment for People With Co-Occurring Disorders in Pychiatric Treatment Settings Robert Drake | |||||
What Kind of Treatment System Is Necessary to Implement Evidence-Based Practices? A. Thomas McLellan, Ph.D. | |||||
S27. Not Just Dopamine any More: Emerging Glutamatergic Therapies for Schizophrenia
Endogenous Modulators of Glutamatergic Neurotransmission and the Pathophysiology of Schizophrenia Joseph T. Coyle Jr. | |||||
AMPA Agonists Agonists (Ampakines) in Schizophrenia Donald C. Goff, M.D. | |||||
The PCP Model of Schizophrenia: 45 Years and Counting Daniel Javitt, M.D. | |||||
NMDA Glycine Site Agonists in the Treatment of the Schizophrenia Prodome Scott W. Woods, M.D. | |||||
S28. CANMAT Guidelines for the Management of Bipolar Disorder: An Effort Toward International Consensus
Foundations of Management: Applying Chronic Disease Models and Psychosocial Interventions to Bipolar Disorder Sagar V. Parikh, M.D. | |||||
CANMAT Guidelines for Acute and Continuation Treatment of Mania Lakshmi N. Yatham, M.D. | |||||
Acute Management of Bipolar Depression Sidney H. Kennedy, M.D. | |||||
Bipolar II Disorder: Emerging Guidelines for Treatment Claire M. O'Donovan, M.B. | |||||
U.S. and International Perspective on CANMAT Guidelines for Bipolar Disorder Joseph R. Calabrese, M.D. | |||||
S29. Dementia in Patients With Down Syndrome: Risk Factors, Biomarkers, Diagnosis, and Treatment
Risk Factors and Biomarkers for Dementia in Adults With Down Syndrome Nicole Schupf, Ph.D. | |||||
Cognitive Assessment of Aging Persons With Down Syndrome Arthur Dalton, Ph.D. | |||||
Trials to Assess Treatment Strategies for Dementia in Down Syndrome Mary Sano, Ph.D. | |||||
S30. Geriatric Psychiatry: New Ideas and New Practices for the 21st Century
Pharmacogenomics in Clinical Practice and Research Larry Ereshefsky, Pharm.D. | |||||
The Future of Magnetic and Electrical Stimulation Therapies in Geriatrics Sarah H. Lisanby, M.D. | |||||
New Pharmaceuticals Sandra A. Jacobson, M.D. | |||||
Best New Technologies for Improved Patient Care Myron L. Pulier, M.D. | |||||
S31. Nancy Andreasen: Festschrift for Her 13 Years as Journal Editor
Scientific Journals and the Transmission of Knowledge to Clinicians Floyd E. Bloom, M.D. | |||||
Interaction Between Gene Expression and Social Behavior Leon Eisenberg, M.D. | |||||
Brain Imaging and the Human Brain at Work Marcus Raichle, M.D. | |||||
The History of Episodic Memory Endel Tulving, Ph.D. | |||||
S32. A Spanish Language Update on the Assessment and Management of DepressionAmerican Society of Hispanic Psychiatry
Update on the Neurobiology of Depression Pedro L. Delgado, M.D. | |||||
Suicide Maria A. Oquendo, M.D. | |||||
Treatment of Depression in Parkinson's Disease Humberto Marin, M.D. | |||||
Depression in Cognitive-Intact and Cognitive-Impaired Elderly Persons Jacobo E. Mintzer, M.D. | |||||
S33. Recent Advances in Clinical Care and Clinical Research in BPD
Course of Acute and Temperamental Symptoms of Borderline Personality Disorder Over 10 Years of Prospective Follow-Up Mary C. Zanarini, Ed.D. | |||||
Affective Instability and Suicidality in Borderline Personality Paul S. Links, M.D. | |||||
Effectiveness of Inpatient Dialectical Behavioral Therapy for Borderline Personality Disorder: A Controlled Trial and Follow-Up Data Martin Bohus, M.D. | |||||
Empirical Observations on the Relationship of Borderline Personality Disorder and Bipolar Disorders John G. Gunderson, M.D. | |||||
Randomized Control Trial of Psychodynamic Treatments Compared With DBT for Borderline Personality Disorder John F. Clarkin, Ph.D. | |||||
2 p.m.-5:30 p.m.
Advances in PsychopharmacologyAlan F. Schatzberg, M.D.
3 p.m.-5 p.m.
New Research Poster Session 5
5:30 p.m.-6:30 p.m.
Convocation of Distinguished Fellows
Lecture
L10. Connecting the Dots: The Interacting Problems of PovertyDavid K. Shipler, William C. Memorial Lecture
7 p.m.-10 p.m.
Industry-Supported Symposia
IS29. Pharmacotherapy of Psychotic and Mood Disorders With Co-Existing Medical IllnessSupported by AstraZeneca Pharmaceuticals
Optimal Selection of Pharmacotherapy in Psychotic and Mood Disorders With Co-Existing Metabolic Disorders Henry A. Nasrallah, M.D. | |||||
Patients With Mental Illness and Cancer Diana O. Perkins, M.D. | |||||
Pharmacotherapy of Psychotic and Mood Disorders in the Context of Thromboembolic Disease Quinton E. Moss, M.D. | |||||
When Mental Illness Is Complicated by Respiratory Symptoms: Management Implications Peter J. Weiden, M.D. | |||||
When HIV Complicates Psychosis or Mood Disorder: Pharmacotherapeutic Considerations and Drug Interactions Glenn J. Treisman, M.D. | |||||
Photo: Tourism Toronto
IS30. Helping Depressed Patients Achieve Remission: Advocacy for ImprovementSupported by Bristol-Myers Squibb Co.
Heterogeneity in Response and Remission: Implications for Optimizing Treatment A. John Rush, M.D. | |||||
Switching Treatments: For Whom and to What Effect? Maurizio Fava, M.D. | |||||
Optimizing Antidepressant Treatments: Use of Augmentations and Combinations to Achieve Remission Andrew A. Nierenberg, M.D. | |||||
Psychotherapy: For Whom and To What Effect? Michael E. Thase, M.D. | |||||
Pharmacogenetics: Can We Customize the Treatments of Depression? Roy H. Perlis, M.D. | |||||
IS31. Understanding and Managing the Transition of ADHD From Adolescence to Young Adulthood: The Maturation of the DisorderSupported by Shire US Inc.
Imaging the Brains of ADHD Adults: New Findings George Bush, M.D. | |||||
ADHD “Not Otherwise Specified”: Conceptual Issues Stephen V. Faraone, Ph.D. | |||||
ADHD Behind the Wheel: Driving With ADHD Craig B.H. Surman, M.D. | |||||
ADHD Goes to College: Planning, Protecting, and Prospering Sharon B. Wigal, Ph.D. | |||||
Emerging Therapies in the Treatment of ADHD Timothy E. Wilens, M.D. | |||||
IS32. The Cognition, Neurocircuitry, and Disability Interface: Bringing Evidence to PracticeSupported by Cephalon Inc.
The Neurocircuitry of Cognition John H. Krystal, M.D. | |||||
Cognition: What Is the Role of Genetics? Daniel R. Weinberger, M.D. | |||||
Cognition, Attention, and Executive Function: How Do They Translate in Our Patients? Philip D. Harvey, Ph.D. | |||||
From Brain to Bedside: Understanding the Clinical Interface of Cognition and Neurocircuity of Depression Boadie W. Dunlop, M.D. | |||||
Novel Treatments for Cognitive Enhancement: Can Drugs Make People Smarter? Trevor Robbins, Ph.D. | |||||
IS33. Taking Control of Negative Symptoms: The Next Step for Improved Patient Outcomes in SchizophreniaSupported by Organon USA Inc. and Pfizer Inc.
Recognizing Negative Symptoms and Their Importance Joseph M. Pierre, M.D. | |||||
Psychosis Circuits, Negative Symptoms, and Brain Imaging Steven G. Potkin, M.D. | |||||
Treatment of Negative Symptoms Hans-Juergen Moeller, M.D. | |||||
Positive Outcomes With Negative Symptoms: Measuring and Monitoring Your Patients Dawn I. Velligan, Ph.D. ▪ | |||||
